Inland Norway University of Applied Sciences
Lillehammer, Norway
NCT Number: NCT04545190
The aim of the study is to investigate the effects of ingesting glucose during five bouts of resistance exercise on muscle biological charateristics in m. vastus lateralis of moderately trained healthy individuals (20-45 years of age, n=20)
Looking for future studies?
Notify Me20 year–45 year
All sexes
Interventional
Not applicable
Lillehammer, Norway
Muscular responses to resistance training vary extensively between humans, with many showing impaired growth. In such individuals, cellular plasticity is compromised, leading to reduced functional and health-beneficial outcomes of training. While this is likely due to a range of determinants, including epigenetic, genetic and physiological variables, recent studies suggest that it involves reduced ability to produce novel ribosomes in response to training. This eventually leads to less pronounced increases in protein synthesis, and thus decreased growth rates, and makes ribosomal content in muscle a potential proxy marker for training-associated muscle hypertrophy.
In a recent study, the investigators showed that increased resistance training volume was associated with more pronounced muscle growth, a trait that was associated with increased ribosomal biogenesis. Despite this, ~50 % of the participants did not exhibit true beneficial effects of increased training volume, which in turn coincided with reduced abilities to accumulate ribosomes. In such individuals, other means are likely necessary to circumvent the negative influence of genetic and epigenetic predispositions on muscle plasticity. Nutrient supplementation stand out as a potential therapy. However, at present, knowledge with regard to this perspective is limited to a selected few nutrients, with protein ingestion being the best studied potential adjuvant, for which adequate intake seems to be essential for achieving optimal muscle growth, potentially being interconnected with ribosomal synthesis. For other nutrients, such as glucose, little is know about their importance for muscle plasticity and ribosomal biogenesis.
In cell types such as cultivated kidney cells, exposure to high levels of glucose is an efficient mean to increase ribosomal biogenesis (and growth rates). This suggests that glucose is an important signaling molecule for increasing ribosomal production per se, perhaps acting as a ligand for signaling proteins or by acting to increase energy availability. In the human body (as opposed to cultured cells), glucose may also exert growth-stimulating effects by increasing insulin levels in blood. Overall, it thus seems plausible that glucose intake during resistance training may stimulate ribosomal biogenesis, in turn having beneficial effects for protein synthesis and muscle plasticity, perhaps acting in an additive manner to protein supplementation. At present, we do not know if this is the case, though studies have suggested that glucose ingestion during acute resistance training sessions may reduce training-induced muscle damage without affecting within-session work output (i.e. volume). This lack of knowledge is surprising given the long-standing appreciation of the beneficial effects of glucose intake for endurance performance, acting to delay muscular fatigue.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To investigate the effects of glucose intake during resistance training on muscle biological adaptations
Time frame: Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)
Total RNA content in m. vastus lateralis (ug per mg tissue)
Time frame: Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)
Abundances of ribosomal RNA species in m. vastus lateralis measured using qPCR
Time frame: Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)
Abundances of protein species in m. vastus lateralis measured using Western blotting (e.g. ECM proteins)
Time frame: Before the intervention and immediately after the intervention (i.e. after 5 training sessions of each leg)
Abundances of mRNA species in m. vastus lateralis measured using qPCR
Time frame: Immediately after the intervention
Protein synthesis rate measured using heavy water (deuterium) and chromatography/spectrometry
Time frame: Immediately before glucose/placebo intake and 30 min, 45 min, 60 min and 195 min after initial glucose/placebo intake
Glucose concentrations in blood (area under the curve), measured before and after intake of glucose/placebo on the two final days of the intervention (one day = glucose; one day = placebo)
Time frame: Immediately before protein intake and 45 min and 90 min after protein intake
Glucose concentrations in blood (area under the curve), measured before and after intake of protein on the two final days of the intervention
Time frame: Immediately before glucose/placebo intake and 30 min and 60 min after the initial glucose/placebo intake
Abundances of insulin, c-peptide, testosterone, growth hormone, cortisol and inflammatory markers in blood (area under the curve), measured before and after intake of glucose/placebo on the two final days of the intervention (one day = glucose; one day = placebo)
Time frame: Immediately before protein intake and 90 min after protein intake
Abundances of insulin, c-peptide, testosterone, growth hormone, cortisol and inflammatory markers in blood, measured after intake of protein on the two final days of the intervention
Time frame: Before the intervention and after the second, fourth and sixth training session
The ability of the knee extensors to exert maximal force during isokinetic movements (recovery/strength), measured before the intervention and at three time points during the intervention (~24 hours after training sessions)
Time frame: Before the last training session and 30 min, 120 min and 24 hours after the last training session
The ability of the knee extensors to exert maximal force during isokinetic movements (recovery/strength), measured before and at three time points after the last two training sessions (one day = glucose; one day = placebo)
Time frame: Before the intervention and after the second, fourth and sixth training session
The ability of the knee extensors to exert maximal force during isometric actions (recovery/strength), measured before the intervention and at three time points during the intervention (~24 hours after training sessions)
Time frame: Before the last training session and 30 min, 120 min and 24 hours after the last training session
The ability of the knee extensors to exert maximal force during isometric actions (recovery/strength), measured before and at three time points after the last two training sessions (one day = glucose; one day = placebo)
Time frame: Before the intervention and 24 hours after each training session
Muscular soreness measured before the intervention and at three time points during the intervention (~24 hours after training sessions) using a VAS-scale from 0 to 10 (0 = no soreness; 10 = maximal soreness)
Time frame: 30 min after each training session
Feeling of the legs measured immediately after each training session using a 9-point scale (1 = very very good, 9 = very very heavy)
Time frame: During each training session of the intervention
Training volume (total kg lifted) during each day of the intervention
Time frame: Prior to the intervention
Body mass composition measured using DXA
Time frame: During each day of the intervention
Nutritional intake during each day of the intervention, tracked using MyFitnessPal
Time frame: Before the intervention
The ability of muscles of the lower body to exert maximal force during dynamic movements
Time frame: Immediately after the intervention
The ability to discriminate between glucose and placebo beverages, tested after the training intervention using a blinded randomized design: each participant will ingest six beverages (3 x glucose and 3 x placebo) and will be asked to identify theam as either glucose or placebo. The "ability to discriminate" will be determined based on analyses of the full study population
Time frame: On each day of the intervention
Deuterium levels in spit on each day during the intervention measured using chromatography/spectrometry (sampled prior to each training session)
Time frame: Before the intervention and immediately after the intervention
Fasting blood glucose measured in serum, measured before the intervention and prior to training on the last two days of the intervention
Inland Norway University of Applied Sciences
Other
RibOSE - Effects of Glucose Ingestion During Resistance Exercise Training on Ribosomal Biogenesis in Skeletal Muscle
Acronym: RibOSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details